INNOVATE CORP (VATE) Fundamental Analysis & Valuation

NYSE:VATE • US45784J3032

Current stock price

11.8 USD
-0.2 (-1.67%)
Last:

This VATE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. VATE Profitability Analysis

1.1 Basic Checks

  • VATE had negative earnings in the past year.
  • VATE had a positive operating cash flow in the past year.
  • In the past 5 years VATE always reported negative net income.
  • VATE had a positive operating cash flow in 4 of the past 5 years.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M 300M

1.2 Ratios

  • VATE has a worse Return On Assets (-6.74%) than 81.82% of its industry peers.
Industry RankSector Rank
ROA -6.74%
ROE N/A
ROIC N/A
ROA(3y)-4.79%
ROA(5y)-7.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

  • VATE has a worse Operating Margin (2.30%) than 70.91% of its industry peers.
  • VATE's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 16.03%, VATE perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
  • In the last couple of years the Gross Margin of VATE has declined.
Industry RankSector Rank
OM 2.3%
PM (TTM) N/A
GM 16.03%
OM growth 3Y18.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.83%
GM growth 5Y-2.2%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. VATE Health Analysis

2.1 Basic Checks

  • VATE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VATE has been increased compared to 1 year ago.
  • Compared to 5 years ago, VATE has less shares outstanding
  • Compared to 1 year ago, VATE has an improved debt to assets ratio.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • VATE has an Altman-Z score of -0.10. This is a bad value and indicates that VATE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.10, VATE is doing worse than 89.09% of the companies in the same industry.
  • VATE has a debt to FCF ratio of 5.49. This is a neutral value as VATE would need 5.49 years to pay back of all of its debts.
  • VATE has a better Debt to FCF ratio (5.49) than 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.49
Altman-Z -0.1
ROIC/WACCN/A
WACC6.01%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • VATE has a Current Ratio of 0.44. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.44, VATE is not doing good in the industry: 94.55% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.42 indicates that VATE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.42, VATE is doing worse than 94.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.42
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. VATE Growth Analysis

3.1 Past

  • The earnings per share for VATE have decreased strongly by -190.01% in the last year.
  • The Revenue has grown by 12.55% in the past year. This is quite good.
  • The Revenue has been growing by 11.69% on average over the past years. This is quite good.
EPS 1Y (TTM)-190.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.03%
Revenue 1Y (TTM)12.55%
Revenue growth 3Y-8.7%
Revenue growth 5Y11.69%
Sales Q2Q%61.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2023 0 10 -10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. VATE Valuation Analysis

4.1 Price/Earnings Ratio

  • VATE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VATE indicates a rather cheap valuation: VATE is cheaper than 85.45% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VATE indicates a rather cheap valuation: VATE is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.34
EV/EBITDA 12.07
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VATE Dividend Analysis

5.1 Amount

  • VATE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VATE Fundamentals: All Metrics, Ratios and Statistics

INNOVATE CORP

NYSE:VATE (5/1/2026, 7:00:00 PM)

11.8

-0.2 (-1.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Industry Strength91.93
Industry Growth93.17
Earnings (Last)03-26
Earnings (Next)05-04
Inst Owners18.22%
Inst Owner Change-1.65%
Ins Owners51.73%
Ins Owner Change-0.4%
Market Cap161.07M
Revenue(TTM)1.25B
Net Income(TTM)-64.00M
Analysts82.86
Price TargetN/A
Short Float %5.52%
Short Ratio8.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.16
Dividend Growth(5Y)14.33%
DP-3.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF 1.34
P/OCF 1.1
P/B N/A
P/tB N/A
EV/EBITDA 12.07
EPS(TTM)-4.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)8.83
FCFY74.81%
OCF(TTM)10.74
OCFY91.02%
SpS91.28
BVpS-16.79
TBVpS-38.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.74%
ROE N/A
ROCE -34.17%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 2.3%
PM (TTM) N/A
GM 16.03%
FCFM 9.67%
ROA(3y)-4.79%
ROA(5y)-7.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)-6.15%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y18.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.83%
GM growth 5Y-2.2%
F-Score4
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.49
Debt/EBITDA 1.36
Cap/Depr 85.86%
Cap/Sales 2.09%
Interest Coverage 0.96
Cash Conversion 248.05%
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.42
Altman-Z -0.1
F-Score4
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)64.91%
Cap/Depr(5y)61.57%
Cap/Sales(3y)1.7%
Cap/Sales(5y)1.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-190.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.55%
Revenue growth 3Y-8.7%
Revenue growth 5Y11.69%
Sales Q2Q%61.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.78%
EBIT growth 3Y7.97%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1317.17%
FCF growth 3YN/A
FCF growth 5Y22.27%
OCF growth 1Y1510.99%
OCF growth 3YN/A
OCF growth 5Y18.82%

INNOVATE CORP / VATE Fundamental Analysis FAQ

What is the fundamental rating for VATE stock?

ChartMill assigns a fundamental rating of 2 / 10 to VATE.


What is the valuation status for VATE stock?

ChartMill assigns a valuation rating of 2 / 10 to INNOVATE CORP (VATE). This can be considered as Overvalued.


How profitable is INNOVATE CORP (VATE) stock?

INNOVATE CORP (VATE) has a profitability rating of 2 / 10.


What is the financial health of INNOVATE CORP (VATE) stock?

The financial health rating of INNOVATE CORP (VATE) is 2 / 10.


Is the dividend of INNOVATE CORP sustainable?

The dividend rating of INNOVATE CORP (VATE) is 0 / 10 and the dividend payout ratio is -3.44%.